Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

DLBCL · Diffuse Large B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China
Sheng · fyyshenglixia@nbu.edu.cn · 0574-87089203

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Non-Hodgkin's Lymphoma · Diffuse Large B-Cell Lymphoma · DLBCL

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Lymphoma · Waldenström Macroglobulinemia (WM) · DLBCL - Diffuse Large B Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Richmond, Australia · Nedlands, Australia

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea